NTRK2 and Alzheimer disease: Direct evidence for the involvement of alterations in BDNF/TrkB signalling in AD is supported by studies indicating that TrkB levels are profoundly decreased in the hippocampus, frontal and temporal cortex of patients with Alzheimer’s [18], although apparently not in the parietal cortex [19].